Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of the Benefit Provided by Sessions of Sophrology on the Per Operative Management of Parkinsonian Patients Planned for a Deep Brain Stimulation Surgery.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adult patient (age greater than or equal to 18 years)~* Patient with idiopathic Parkinson's disease with programmed deep brain stimulation (VIM target, NST, single or bilateral GPI);~* Planned intervention in an awake patient (implying MOCA\> 21 (Montreal Cognitive Assessment));~* Patient understanding the course of the study;~* Patient who has given informed consent in writing;~* Patient benefiting from a system of social insurance.~Exclusion Criteria:~* - Intervention under general anesthesia;~* Pregnant or nursing women;~* Major person under protective measures (safeguard of justice, curatorship and guardianship);~* Person deprived of liberty.~* Patient having already had a practice in yoga, sophrology, hypnotherapy superior or equal to 5 sessions

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Patients without sessions of sophrology (Type: NO_INTERVENTION): The control group is also composed of Parkinsonian patients waiting for deep brain surgery but will not have any special preparation for the procedure. They will be subjected to the same assessments at the same time as the sophrology group.
- Patients with sessions of sophrology (Type: EXPERIMENTAL): The experimental group is composed of patients with Parkinson's waiting for deep brain surgery. They will benefit from 10 sessions of sophrology in preparation for the intervention 5 weeks before this one.

Based on this trial design, predict the completion outcome and termination type (if applicable).